Evans Alexander R, Villeneuve Lance, Bowen Ira, Carter Lacey, Chen Sixia, Kimmell Marianne, Gernsback Joanna, Balsara Karl, Jea Andrew, Desai Virendra R
1Division of Pediatric Neurosurgery, Oklahoma Children's Hospital, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City; and.
2Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
J Neurosurg Pediatr. 2024 May 31;34(2):176-181. doi: 10.3171/2024.4.PEDS23572. Print 2024 Aug 1.
The goal of this study was to evaluate the impact of endoscopic third ventriculostomy (ETV) failure on subsequent risk of ventriculoperitoneal shunt (VPS) placement.
A retrospective chart review was performed to identify pediatric patients receiving ETV followed by a VPS at Oklahoma Children's Hospital between January 1, 2016, and December 31, 2021. A control group of patients receiving a VPS alone was also gathered. Complication and shunt failure rates were compared between the 2 groups at 12 months postoperatively.
A total of 222 patients were included in this study. The VPS placement after ETV failure (VPSEF) group included 21 patients; 53% were male and 47% were female, with a mean age of 2.2 years and standard deviation of 4.3 years. The etiology of hydrocephalus was chiefly intraventricular hemorrhage (43%) and neural tube defects (19%). At 12 months after VPS placement, the complication rate was 24%, predominantly including infection (19%) or CSF leakage (10%). The VPS-only (VPSO) group included 201 patients; 51% were male and 49% were female, with a mean age of 4.2 years and standard deviation of 6.5 years. The etiology of hydrocephalus was chiefly intraventricular hemorrhage (26%) and neural tube defects (30%). At 12 months postoperatively, the complication rate was 10%, predominantly including infection (6%) or catheter-associated hemorrhage (3%). The difference in complication rates between the VPSEF and VPSO groups was not significant at 12 months postoperatively (p = 0.07); however, on subgroup analysis there was a significantly higher rate of CSF leakage at 12 months in the VPSEF group compared to the VPSO group (p = 0.0371).
There was no difference in overall complication rates for the treatment of pediatric hydrocephalus by VPS following failed ETV compared to VPS placement alone, yet prior ETV may predispose patients to a higher rate of CSF leaks within 12 months of VPS placement. Further study is indicated to determine whether a prior ETV procedure predisposes patients to a higher complication rate on VPS placement.
本研究的目的是评估内镜下第三脑室造瘘术(ETV)失败对随后行脑室腹腔分流术(VPS)的风险影响。
进行一项回顾性病历审查,以确定2016年1月1日至2021年12月31日期间在俄克拉荷马儿童医院接受ETV并随后接受VPS的儿科患者。还收集了仅接受VPS的对照组患者。比较两组术后12个月时的并发症和分流失败率。
本研究共纳入222例患者。ETV失败后行VPS(VPSEF)组包括21例患者;53%为男性,47%为女性,平均年龄2.2岁,标准差4.3岁。脑积水的病因主要是脑室内出血(43%)和神经管缺陷(19%)。在VPS置入后12个月时,并发症发生率为24%,主要包括感染(19%)或脑脊液漏(10%)。仅行VPS(VPSO)组包括201例患者;51%为男性,49%为女性,平均年龄4.2岁,标准差6.5岁。脑积水的病因主要是脑室内出血(26%)和神经管缺陷(30%)。术后12个月时,并发症发生率为10%,主要包括感染(6%)或导管相关出血(3%)。VPSEF组和VPSO组术后12个月时的并发症发生率差异无统计学意义(p = 0.07);然而,亚组分析显示,VPSEF组术后12个月时脑脊液漏发生率显著高于VPSO组(p = 0.0371)。
与单纯行VPS相比,ETV失败后行VPS治疗小儿脑积水的总体并发症发生率无差异,但先前的ETV可能使患者在VPS置入后12个月内脑脊液漏发生率更高。需要进一步研究以确定先前的ETV手术是否使患者在VPS置入时并发症发生率更高。